Double Medical Technology Inc
SZSE:002901

Watchlist Manager
Double Medical Technology Inc Logo
Double Medical Technology Inc
SZSE:002901
Watchlist
Price: 32.41 CNY -1.01% Market Closed
Market Cap: 13.4B CNY
Have any thoughts about
Double Medical Technology Inc?
Write Note

Double Medical Technology Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Double Medical Technology Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Double Medical Technology Inc
SZSE:002901
Income from Continuing Operations
ÂĄ135.4m
CAGR 3-Years
-41%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Income from Continuing Operations
ÂĄ522.1m
CAGR 3-Years
71%
CAGR 5-Years
99%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Income from Continuing Operations
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Income from Continuing Operations
ÂĄ12.4B
CAGR 3-Years
16%
CAGR 5-Years
23%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Income from Continuing Operations
ÂĄ794.1m
CAGR 3-Years
-11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Income from Continuing Operations
ÂĄ2B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Double Medical Technology Inc
Glance View

Market Cap
13.4B CNY
Industry
Health Care

Double Medical Technology, Inc. engages in production, research and development and sale of medical consumables. The company is headquartered in Xiamen, Fujian and currently employs 3,141 full-time employees. The company went IPO on 2017-09-22. The main products of the Company include orthopedic trauma implant materials, spinal implant materials and nerve surgical implant materials. Also, the Company manufactures surgical instruments. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
31.28 CNY
Overvaluation 3%
Intrinsic Value
Price

See Also

What is Double Medical Technology Inc's Income from Continuing Operations?
Income from Continuing Operations
135.4m CNY

Based on the financial report for Jun 30, 2024, Double Medical Technology Inc's Income from Continuing Operations amounts to 135.4m CNY.

What is Double Medical Technology Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-20%

Over the last year, the Income from Continuing Operations growth was 504%. The average annual Income from Continuing Operations growth rates for Double Medical Technology Inc have been -41% over the past three years , -20% over the past five years .

Back to Top